# Safety and Tolerability of Acanya Gel in Combination With Atralin Gel for Acne Vulgaris

> **NCT01448733** · PHASE4 · UNKNOWN · sponsor: **Zeichner, Joshua, M.D.** · enrollment: 20 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Benzoyl peroxide 2.5%/clindamycin phosphate 1.2% in the morning with with tretinoin 0.05% gel in the evening

## Key facts

- **NCT ID:** NCT01448733
- **Lead sponsor:** Zeichner, Joshua, M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-07
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2011-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01448733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01448733, "Safety and Tolerability of Acanya Gel in Combination With Atralin Gel for Acne Vulgaris". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01448733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*